• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司洗脱支架置入术后的多重连续并发症:极晚期支架血栓形成、支架断裂、支架内再狭窄和支架周围动脉瘤。

Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.

机构信息

Department of Medicine, Inje University College of Medicine, Busan Paik Hospital, Busan, Korea.

出版信息

Korean Circ J. 2009 Oct;39(10):439-42. doi: 10.4070/kcj.2009.39.10.439. Epub 2009 Oct 28.

DOI:10.4070/kcj.2009.39.10.439
PMID:19949591
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2771792/
Abstract

A 55-year-old male patient presented with an acute myocardial infarction. A sirolimus-eluting stent (SES) was implanted in the proximal left anterior descending artery (LAD). Eight months later, there was a newly developed distal LAD lesion. An additional SES was implanted. Twenty-eight months after the index procedure of primary coronary intervention, the electrocardiogram showed ST elevation in the precordial leads and an emergency coronary angiogram showed diffuse stent thrombosis (ST) in the proximal LAD. Thirty-four months after the index procedure, coronary angiography showed a large peri-stent coronary aneurysm in the proximal LAD and focal in-stent restenosis (ISR) at the proximal edge of the distal LAD stent. On fluoroscopy, a fracture was noted in the middle part of the distal SES. A zotarolimus- eluting stent (ZES) was deployed and overlapped the restenosis and fracture sites. Forty months after the index procedure, there were no changes in the size of the aneurysm or in the other stent complications including the fracture and restenosis. At present, the patient has remained asymptomatic for eight months.

摘要

一位 55 岁男性患者因急性心肌梗死就诊。在其左前降支(LAD)近端植入了一个西罗莫司洗脱支架(SES)。八个月后,LAD 远端出现新的病变。再次植入一个 SES。在初次经皮冠状动脉介入治疗后的 28 个月,心电图显示心前区导联 ST 段抬高,紧急冠状动脉造影显示 LAD 近端弥漫性支架血栓形成(ST)。初次经皮冠状动脉介入治疗后 34 个月,冠状动脉造影显示 LAD 近端支架附近有一个大的支架周围动脉瘤和 LAD 远端支架近端边缘的局灶性支架内再狭窄(ISR)。透视下发现远端 SES 的中部有一处断裂。植入了一个佐他莫司洗脱支架(ZES),并覆盖了再狭窄和断裂部位。初次经皮冠状动脉介入治疗后 40 个月,动脉瘤大小或其他支架并发症(包括断裂和再狭窄)没有变化。目前,患者无任何症状已持续 8 个月。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/9e8c1ae02813/kcj-39-439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/b540744f4de5/kcj-39-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/b26eb51e5758/kcj-39-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/6259ed64c85c/kcj-39-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/9e8c1ae02813/kcj-39-439-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/b540744f4de5/kcj-39-439-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/b26eb51e5758/kcj-39-439-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/6259ed64c85c/kcj-39-439-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/954d/2771792/9e8c1ae02813/kcj-39-439-g004.jpg

相似文献

1
Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.西罗莫司洗脱支架置入术后的多重连续并发症:极晚期支架血栓形成、支架断裂、支架内再狭窄和支架周围动脉瘤。
Korean Circ J. 2009 Oct;39(10):439-42. doi: 10.4070/kcj.2009.39.10.439. Epub 2009 Oct 28.
2
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).晚期临床结果与佐他莫司和西罗莫司洗脱支架。ENDEAVOR III 试验(美敦力 Endeavor 药物 [ABT-578]洗脱冠状动脉支架系统与 Cypher 西罗莫司洗脱冠状动脉支架系统在初发原生冠状动脉病变中的随机对照试验)的 5 年随访结果。
JACC Cardiovasc Interv. 2011 May;4(5):543-50. doi: 10.1016/j.jcin.2010.12.014.
3
Drug-eluting stent as an option for intractable in-stent coronary restenosis.药物洗脱支架作为治疗难治性支架内冠状动脉再狭窄的一种选择。
Korean Circ J. 2011 Nov;41(11):677-80. doi: 10.4070/kcj.2011.41.11.677. Epub 2011 Nov 29.
4
Non-invasive recanalization of first-generation sirolimus-eluting stent thrombosis due to stent fracture and coronary artery aneurysm after clopidogrel treatment 15 years after implantation.植入15年后,在氯吡格雷治疗后,因支架断裂和冠状动脉瘤导致的第一代西罗莫司洗脱支架血栓形成的无创再通
J Cardiol Cases. 2024 Feb 2;29(5):209-213. doi: 10.1016/j.jccase.2024.01.004. eCollection 2024 May.
5
Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.药物涂层支架治疗支架内再狭窄患者的临床结果:一项汇总分析的 2 年结果。
JACC Cardiovasc Interv. 2013 Sep;6(9):905-13. doi: 10.1016/j.jcin.2013.04.017. Epub 2013 Aug 14.
6
Proximal left anterior descending coronary artery revascularization with drug-eluting stents.使用药物洗脱支架对左冠状动脉前降支近端进行血运重建。
Arq Bras Cardiol. 2007 Feb;88(2):159-66. doi: 10.1590/s0066-782x2007000200005.
7
Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trials.载唑雷莫司洗脱支架与西罗莫司洗脱和紫杉醇洗脱支架经皮冠状动脉介入治疗的比较:随机试验的荟萃分析。
Arch Cardiovasc Dis. 2012 Nov;105(11):544-56. doi: 10.1016/j.acvd.2012.01.014. Epub 2012 Nov 9.
8
Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.血管内超声评估佐他莫司、依维莫司和西罗莫司洗脱支架植入后预防支架内再狭窄的最佳支架面积
Catheter Cardiovasc Interv. 2014 May 1;83(6):873-8. doi: 10.1002/ccd.24560. Epub 2013 Nov 9.
9
Very Late Development of Coronary Artery Aneurysm with Total Occlusion following Sirolimus-Eluting Stent Implantation.西罗莫司洗脱支架植入术后冠状动脉瘤伴完全闭塞的极晚期发生
Int J Angiol. 2012 Dec;21(4):229-32. doi: 10.1055/s-0032-1325653.
10
A case report of coronary artery aneurysms with restenosis and stent fractures developed 14 years after sirolimus eluting stents implantation successfully treated with drug-coated balloons.一例西罗莫司洗脱支架植入14年后出现冠状动脉瘤伴再狭窄和支架断裂,经药物涂层球囊成功治疗的病例报告。
Eur Heart J Case Rep. 2024 Jan 29;8(2):ytae050. doi: 10.1093/ehjcr/ytae050. eCollection 2024 Feb.

引用本文的文献

1
Recurrent episode of very late stent thrombosis in a patient who underwent percutaneous coronary intervention with sirolimus-eluting stent: Same or different mechanism?一名接受西罗莫司洗脱支架经皮冠状动脉介入治疗的患者发生极晚期支架血栓复发:机制相同还是不同?
J Cardiol Cases. 2011 Dec 6;5(1):e8-e11. doi: 10.1016/j.jccase.2011.10.007. eCollection 2012 Feb.
2
Decreased expression of vitamin D receptors in neointimal lesions following coronary artery angioplasty in atherosclerotic swine.动脉粥样硬化猪冠状动脉成形术后再狭窄病变中维生素 D 受体表达减少。
PLoS One. 2012;7(8):e42789. doi: 10.1371/journal.pone.0042789. Epub 2012 Aug 6.
3

本文引用的文献

1
Clinical characteristics of stent fracture after sirolimus-eluting stent implantation.西罗莫司洗脱支架植入术后支架断裂的临床特征
Int J Cardiol. 2009 Jan 9;131(2):212-6. doi: 10.1016/j.ijcard.2007.10.059. Epub 2008 Feb 1.
2
Spontaneous resolution of multiple coronary aneurysms complicating drug eluting stent implantation.药物洗脱支架植入术后并发的多个冠状动脉瘤的自发消退
Int J Cardiol. 2008 Oct 30;130(1):e7-10. doi: 10.1016/j.ijcard.2007.07.039. Epub 2007 Sep 25.
3
Stent thrombosis in randomized clinical trials of drug-eluting stents.
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation.
紫杉醇洗脱支架置入后因新生内膜破裂导致的极晚期支架血栓形成。
Korean Circ J. 2011 Dec;41(12):754-8. doi: 10.4070/kcj.2011.41.12.754. Epub 2011 Dec 31.
药物洗脱支架随机临床试验中的支架内血栓形成
N Engl J Med. 2007 Mar 8;356(10):1020-9. doi: 10.1056/NEJMoa067731. Epub 2007 Feb 12.
4
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians.冠状动脉支架置入患者双联抗血小板治疗过早停药的预防:美国心脏协会、美国心脏病学会、心血管造影和介入学会、美国外科医师学会及美国牙科协会的科学咨询意见,美国医师学会也参与其中
J Am Coll Cardiol. 2007 Feb 13;49(6):734-9. doi: 10.1016/j.jacc.2007.01.003.
5
Development of coronary aneurysm after drug-eluting stent implantation.药物洗脱支架植入术后冠状动脉瘤的发生
Ann Intern Med. 2007 Feb 6;146(3):230-2. doi: 10.7326/0003-4819-146-3-200702060-00146.
6
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.在复杂冠状动脉疾病患者中,基于聚合物的紫杉醇洗脱支架与裸金属支架的比较:一项随机对照试验。
JAMA. 2005 Sep 14;294(10):1215-23. doi: 10.1001/jama.294.10.1215.
7
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.药物洗脱支架成功植入后血栓形成的发生率、预测因素及转归
JAMA. 2005 May 4;293(17):2126-30. doi: 10.1001/jama.293.17.2126.
8
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?西罗莫司洗脱支架所致局部超敏反应和迟发性冠状动脉血栓形成:我们应谨慎对待吗?
Circulation. 2004 Feb 17;109(6):701-5. doi: 10.1161/01.CIR.0000116202.41966.D4. Epub 2004 Jan 26.
9
Stent fracture and restenosis in the drug-eluting stent era.药物洗脱支架时代的支架断裂与再狭窄
Catheter Cardiovasc Interv. 2004 Jan;61(1):111-6. doi: 10.1002/ccd.10709.
10
Regional remodeling as the cause of late stent malapposition.局部重塑作为晚期支架贴壁不良的原因。
Circulation. 2003 Jun 3;107(21):2660-3. doi: 10.1161/01.CIR.0000074778.46065.24. Epub 2003 May 27.